Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1991-3-11
|
pubmed:abstractText |
Many peripheral tissues express the proopiomelanocortin (POMC) gene as an 800-base mRNA that lacks the 5' end of the 1200-base pituitary transcript. The missing region encodes the peptide signal sequence, and thus, it is unlikely that any translation product would be secreted. We have found that a RNA transcript equivalent to this short message, generated by transcription in vitro from a T7 polymerase promoter, is translatable in a rabbit reticulocyte lysate, generating peptides of 27.5, 22.5, and 15.5 kD. None of these peptides appears to be processed or protected from proteinase-K digestion by a microsomal membrane fraction. In vivo studies were undertaken by transfecting into GH3 cells one of two expression vectors containing sequences that would produce either a full-length mRNA or a short (800-base) mRNA. The neomycin resistance gene was cotransfected with these plasmids, and 30 permanent cell lines were produced after selection in G418. Cell lines containing the full-length RNA secreted large quantities of ACTH and beta-endorphin immunoreactivity, whereas those expressing the short transcript secreted neither of these peptides. However extractable peptide was present in this latter type of cell line, thereby suggesting that the 800-base mRNA was translated, and that no peptide reached the secretory vesicle. These findings raise important questions about the role of peripheral POMC gene expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenocorticotropic Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Neomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Pro-Opiomelanocortin,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Endorphin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0888-8809
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1737-43
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2177842-Adrenocorticotropic Hormone,
pubmed-meshheading:2177842-Animals,
pubmed-meshheading:2177842-Cell Line,
pubmed-meshheading:2177842-DNA,
pubmed-meshheading:2177842-Drug Resistance,
pubmed-meshheading:2177842-Gene Expression Regulation,
pubmed-meshheading:2177842-Microsomes,
pubmed-meshheading:2177842-Neomycin,
pubmed-meshheading:2177842-Pro-Opiomelanocortin,
pubmed-meshheading:2177842-Promoter Regions, Genetic,
pubmed-meshheading:2177842-RNA, Messenger,
pubmed-meshheading:2177842-RNA Processing, Post-Transcriptional,
pubmed-meshheading:2177842-Rabbits,
pubmed-meshheading:2177842-Rats,
pubmed-meshheading:2177842-Reticulocytes,
pubmed-meshheading:2177842-beta-Endorphin
|
pubmed:year |
1990
|
pubmed:articleTitle |
In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA.
|
pubmed:affiliation |
Department of Endocrinology, St. Bartholomew's Hospital Medical College, London, Great Britain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|